Market Cap 57.88M
Revenue (ttm) 0.00
Net Income (ttm) -36.12M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 3,759,800
Avg Vol 1,655,712
Day's Range N/A - N/A
Shares Out 91.88M
Stochastic %K 0%
Beta 1.61
Analysts Strong Sell
Price Target $5.88

Company Profile

Context Therapeutics Inc., a clinical-stage biopharmaceutical company, develops products for the treatment of solid tumors. The company's product candidate includes CTIM-76, a Claudin 6 (CLDN6) x CD3 bispecific antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. It has a collaboration and licensing agreement with Integral Molecular, Inc. for the development of a CLDN6 bispecific monoclonal antibody for cancer therapy. The company was incorporated...

Industry: Biotechnology
Sector: Healthcare
Phone: 267 225 7416
Address:
2001 Market Street, Suite 3915 Unit #15, Philadelphia, United States
SpencerF
SpencerF Jun. 24 at 9:11 PM
$CNTX hedgies getting ready to do their final flush. Wonder if it will make it to 0 or if the millions of shares shareholders keep will allow it to gurgle around 5 cents for a year
0 · Reply
buymoremakemore
buymoremakemore Jun. 24 at 6:45 PM
$CNTX “If more people join in. The stock will get better” https://youtu.be/3fOFZVpIh9k?is=9WHlr3ktbRAuv2gg
1 · Reply
SpencerF
SpencerF Jun. 24 at 6:38 PM
$CNTX any chance at all once the big pharma shorts get it to 0 they’ll use their products at all with a bug company to help cancer? Or is it pretty much crucial they throw it all in the trash in the name of keeping their industry strong?
0 · Reply
saad545
saad545 Jun. 24 at 6:26 PM
$CNTX shorts spread fud like themselves. The price will reach at least $ 1.5 in the near term. Mark it🔥
1 · Reply
saad545
saad545 Jun. 24 at 6:24 PM
$CNTX The company has cash enough to complete opertions until mid 2027🔥🔥
0 · Reply
mailman1961
mailman1961 Jun. 24 at 5:45 PM
$CNTX Only thing I see in the Annual Meeting is authorized share increase to 300M from 200M, but that's been around since April. So obviously some dilution coming but that's already built into this garbage price. Rest of the meeting is standard bullshit.
1 · Reply
Luckylaura
Luckylaura Jun. 24 at 5:20 PM
$CNTX any reason for this to drop 10% after anual meeting!? where can we hear the meeting?
0 · Reply
SpencerF
SpencerF Jun. 24 at 5:08 PM
$CNTX any end of company closing speech? Or think they’ll just rip the bandaid off and say “we’re done”
0 · Reply
saad545
saad545 Jun. 24 at 5:06 PM
$CNTX added 10K shares, this is significantly undervalued 🔥🔥🔥
1 · Reply
buymoremakemore
buymoremakemore Jun. 24 at 4:19 PM
$CNTX Bought 50k shares at $0.6010
1 · Reply
Latest News on CNTX
Context Therapeutics Transcript: Study result

Jun 15, 2026, 8:00 AM EDT - 9 days ago

Context Therapeutics Transcript: Study result


Context Therapeutics Press release: Study result

Jun 15, 2026, 8:00 AM EDT - 9 days ago

Context Therapeutics Press release: Study result


Context Therapeutics Slides: Study result

Jun 15, 2026, 8:00 AM EDT - 9 days ago

Context Therapeutics Slides: Study result


Context Therapeutics Slides: Corporate presentation

Jun 13, 2026, 7:00 AM EDT - 11 days ago

Context Therapeutics Slides: Corporate presentation


Context Therapeutics reports Q1 EPS (9c), consensus (12c)

2026-05-07T00:54:46.000Z - 7 weeks ago

Context Therapeutics reports Q1 EPS (9c), consensus (12c)


Context Therapeutics Quarterly report: Q1 2026

May 6, 2026, 7:00 AM EDT - 7 weeks ago

Context Therapeutics Quarterly report: Q1 2026


Context Therapeutics Earnings release: Q1 2026

May 6, 2026, 7:00 AM EDT - 7 weeks ago

Context Therapeutics Earnings release: Q1 2026


Context Therapeutics Proxy statement: Proxy filing

Apr 28, 2026, 8:00 AM EDT - 2 months ago

Context Therapeutics Proxy statement: Proxy filing


Context Therapeutics Proxy statement: Proxy filing

Apr 28, 2026, 8:00 AM EDT - 2 months ago

Context Therapeutics Proxy statement: Proxy filing


Context Therapeutics Proxy statement: Proxy filing

Apr 17, 2026, 8:00 AM EDT - 2 months ago

Context Therapeutics Proxy statement: Proxy filing


Context Therapeutics Earnings release: Q4 2025

Mar 23, 2026, 7:00 AM EDT - 3 months ago

Context Therapeutics Earnings release: Q4 2025


Context Therapeutics Annual report: Q4 2025

Mar 23, 2026, 7:00 AM EDT - 3 months ago

Context Therapeutics Annual report: Q4 2025


Context Therapeutics Slides: Corporate presentation

Mar 23, 2026, 7:00 AM EDT - 3 months ago

Context Therapeutics Slides: Corporate presentation


Context Therapeutics initiated with a Buy at JonesResearch

2025-12-22T12:16:26.000Z - 6 months ago

Context Therapeutics initiated with a Buy at JonesResearch


Context Therapeutics reports Q3 EPS (10c), consensus (9c)

2025-11-05T23:00:43.000Z - 8 months ago

Context Therapeutics reports Q3 EPS (10c), consensus (9c)


Context Therapeutics Earnings release: Q3 2025

Nov 5, 2025, 7:00 AM EST - 8 months ago

Context Therapeutics Earnings release: Q3 2025


Context Therapeutics Quarterly report: Q3 2025

Nov 5, 2025, 7:00 AM EST - 8 months ago

Context Therapeutics Quarterly report: Q3 2025


Context Therapeutics management to meet with Maxim

2025-09-29T14:10:09.000Z - 9 months ago

Context Therapeutics management to meet with Maxim


Context Therapeutics initiated with a Buy at Guggenheim

2025-09-17T20:40:12.000Z - 10 months ago

Context Therapeutics initiated with a Buy at Guggenheim


Context Therapeutics initiated with a Buy at Guggenheim

2025-09-17T20:21:12.000Z - 10 months ago

Context Therapeutics initiated with a Buy at Guggenheim


Context Therapeutics management to meet with Maxim

2025-09-10T15:35:13.000Z - 10 months ago

Context Therapeutics management to meet with Maxim


Context Therapeutics Earnings release: Q2 2025

Aug 6, 2025, 12:00 AM EDT - 11 months ago

Context Therapeutics Earnings release: Q2 2025


Context Therapeutics Quarterly report: Q2 2025

Aug 6, 2025, 12:00 AM EDT - 11 months ago

Context Therapeutics Quarterly report: Q2 2025


Context Therapeutics Earnings release: Q1 2025

May 7, 2025, 12:00 AM EDT - 1 year ago

Context Therapeutics Earnings release: Q1 2025


Context Therapeutics Quarterly report: Q1 2025

May 7, 2025, 12:00 AM EDT - 1 year ago

Context Therapeutics Quarterly report: Q1 2025


Context Therapeutics Proxy statement: Proxy Filing

Apr 15, 2025, 8:00 AM EDT - 1 year ago

Context Therapeutics Proxy statement: Proxy Filing


Context Therapeutics Proxy statement: Proxy Filing

Apr 15, 2025, 8:00 AM EDT - 1 year ago

Context Therapeutics Proxy statement: Proxy Filing


Context Therapeutics Proxy statement: Proxy Filing

Apr 4, 2025, 8:00 AM EDT - 1 year ago

Context Therapeutics Proxy statement: Proxy Filing


Context Therapeutics Earnings release: Q4 2024

Mar 19, 2025, 7:00 PM EDT - 1 year ago

Context Therapeutics Earnings release: Q4 2024


Context Therapeutics Annual report: Q4 2024

Mar 19, 2025, 7:00 PM EDT - 1 year ago

Context Therapeutics Annual report: Q4 2024


Context Therapeutics Earnings release: Q3 2024

Nov 6, 2024, 4:00 PM EST - 1 year ago

Context Therapeutics Earnings release: Q3 2024


Context Therapeutics Quarterly report: Q3 2024

Nov 6, 2024, 4:00 PM EST - 1 year ago

Context Therapeutics Quarterly report: Q3 2024


Context Therapeutics Quarterly report: Q2 2024

Aug 7, 2024, 4:00 PM EDT - 2 years ago

Context Therapeutics Quarterly report: Q2 2024


Context Therapeutics Earnings release: Q2 2024

Aug 7, 2024, 4:00 PM EDT - 2 years ago

Context Therapeutics Earnings release: Q2 2024


Context Therapeutics Proxy statement: Proxy Filing

Jul 24, 2024, 8:00 AM EDT - 2 years ago

Context Therapeutics Proxy statement: Proxy Filing


Context Therapeutics Proxy statement: Proxy Filing

Jul 24, 2024, 8:00 AM EDT - 2 years ago

Context Therapeutics Proxy statement: Proxy Filing


Context Therapeutics Proxy statement: Proxy Filing

Jul 12, 2024, 8:00 AM EDT - 2 years ago

Context Therapeutics Proxy statement: Proxy Filing


Context Therapeutics Quarterly report: Q1 2024

May 8, 2024, 7:00 AM EDT - 2 years ago

Context Therapeutics Quarterly report: Q1 2024


Context Therapeutics Earnings release: Q1 2024

May 8, 2024, 7:00 AM EDT - 2 years ago

Context Therapeutics Earnings release: Q1 2024


Context Therapeutics Proxy statement: Proxy Filing

Apr 26, 2024, 8:00 AM EDT - 2 years ago

Context Therapeutics Proxy statement: Proxy Filing


Context Therapeutics Proxy statement: Proxy Filing

Apr 26, 2024, 8:00 AM EDT - 2 years ago

Context Therapeutics Proxy statement: Proxy Filing


Context Therapeutics Earnings release: Q4 2023

Mar 21, 2024, 8:00 AM EDT - 2 years ago

Context Therapeutics Earnings release: Q4 2023


Context Therapeutics Annual report: Q4 2023

Mar 21, 2024, 8:00 AM EDT - 2 years ago

Context Therapeutics Annual report: Q4 2023


Context Therapeutics Quarterly report: Q3 2023

Nov 9, 2023, 7:00 AM EST - 2 years ago

Context Therapeutics Quarterly report: Q3 2023


Context Therapeutics Earnings release: Q3 2023

Nov 9, 2023, 7:00 AM EST - 2 years ago

Context Therapeutics Earnings release: Q3 2023


Context Therapeutics Quarterly report: Q2 2023

Aug 9, 2023, 7:00 AM EDT - 3 years ago

Context Therapeutics Quarterly report: Q2 2023


Context Therapeutics Earnings release: Q2 2023

Aug 9, 2023, 7:00 AM EDT - 3 years ago

Context Therapeutics Earnings release: Q2 2023


Context Therapeutics Quarterly report: Q1 2023

May 10, 2023, 7:00 AM EDT - 3 years ago

Context Therapeutics Quarterly report: Q1 2023


Context Therapeutics Earnings release: Q1 2023

May 10, 2023, 7:00 AM EDT - 3 years ago

Context Therapeutics Earnings release: Q1 2023


Context Therapeutics Proxy statement: Proxy Filing

Apr 6, 2023, 8:00 AM EDT - 3 years ago

Context Therapeutics Proxy statement: Proxy Filing


Context Therapeutics Proxy statement: Proxy Filing

Apr 6, 2023, 8:00 AM EDT - 3 years ago

Context Therapeutics Proxy statement: Proxy Filing


Context Therapeutics Proxy statement: Proxy Filing

Mar 27, 2023, 8:00 AM EDT - 3 years ago

Context Therapeutics Proxy statement: Proxy Filing


Context Therapeutics Earnings release: Q4 2022

Mar 22, 2023, 8:00 AM EDT - 3 years ago

Context Therapeutics Earnings release: Q4 2022


Context Therapeutics Annual report: Q4 2022

Mar 22, 2023, 8:00 AM EDT - 3 years ago

Context Therapeutics Annual report: Q4 2022


SpencerF
SpencerF Jun. 24 at 9:11 PM
$CNTX hedgies getting ready to do their final flush. Wonder if it will make it to 0 or if the millions of shares shareholders keep will allow it to gurgle around 5 cents for a year
0 · Reply
buymoremakemore
buymoremakemore Jun. 24 at 6:45 PM
$CNTX “If more people join in. The stock will get better” https://youtu.be/3fOFZVpIh9k?is=9WHlr3ktbRAuv2gg
1 · Reply
SpencerF
SpencerF Jun. 24 at 6:38 PM
$CNTX any chance at all once the big pharma shorts get it to 0 they’ll use their products at all with a bug company to help cancer? Or is it pretty much crucial they throw it all in the trash in the name of keeping their industry strong?
0 · Reply
saad545
saad545 Jun. 24 at 6:26 PM
$CNTX shorts spread fud like themselves. The price will reach at least $ 1.5 in the near term. Mark it🔥
1 · Reply
saad545
saad545 Jun. 24 at 6:24 PM
$CNTX The company has cash enough to complete opertions until mid 2027🔥🔥
0 · Reply
mailman1961
mailman1961 Jun. 24 at 5:45 PM
$CNTX Only thing I see in the Annual Meeting is authorized share increase to 300M from 200M, but that's been around since April. So obviously some dilution coming but that's already built into this garbage price. Rest of the meeting is standard bullshit.
1 · Reply
Luckylaura
Luckylaura Jun. 24 at 5:20 PM
$CNTX any reason for this to drop 10% after anual meeting!? where can we hear the meeting?
0 · Reply
SpencerF
SpencerF Jun. 24 at 5:08 PM
$CNTX any end of company closing speech? Or think they’ll just rip the bandaid off and say “we’re done”
0 · Reply
saad545
saad545 Jun. 24 at 5:06 PM
$CNTX added 10K shares, this is significantly undervalued 🔥🔥🔥
1 · Reply
buymoremakemore
buymoremakemore Jun. 24 at 4:19 PM
$CNTX Bought 50k shares at $0.6010
1 · Reply
Chevau
Chevau Jun. 24 at 4:15 PM
$CNTX buying more
0 · Reply
Rounderssss4
Rounderssss4 Jun. 24 at 3:02 PM
$CNTX someone really wants this down on the daily
1 · Reply
Svadowv
Svadowv Jun. 24 at 11:45 AM
$CNTX any upcoming catalysts?
2 · Reply
Pain_without_Mercy
Pain_without_Mercy Jun. 23 at 2:48 PM
$CNTX maybe some news on it´s way
0 · Reply
Rounderssss4
Rounderssss4 Jun. 23 at 2:15 PM
$CNTX can we be done with these '60s already
0 · Reply
Rounderssss4
Rounderssss4 Jun. 23 at 12:43 PM
$RGNT need a big green day here $ELTX $CELC $CNTX
1 · Reply
Nate_Dubski
Nate_Dubski Jun. 23 at 11:57 AM
$CNTX Ready to make some $$$$$
1 · Reply
Mike_Rotsch
Mike_Rotsch Jun. 22 at 7:59 PM
$CNTX Yep. This is it. Got in at .6124. It's correction time.
0 · Reply
SpencerF
SpencerF Jun. 22 at 6:40 PM
$CNTX looks like it’s about time to say goodnight
0 · Reply
J1476
J1476 Jun. 22 at 4:20 PM
$CNTX back in!
0 · Reply
Autolus_Freakk
Autolus_Freakk Jun. 22 at 2:25 PM
$CNTX start the climb up from middle of this week...
0 · Reply
PLATINUM_TRADES
PLATINUM_TRADES Jun. 22 at 1:53 PM
$CNTX 👇👇 $.695 high close enough! Another overnight swing winner stay green 🌳 all month 🥇🥇
0 · Reply